cause image
gauge image
effect image

This individual's Guiltiness is generally lowest after a daily total of 100 milligrams of Eldepryl By Orion Pharma intake over the previous 7 days.
Join This Study
Go To Interactive Study
Blue represents the sum of Eldepryl By Orion Pharma intake over the previous 7 days
An increase in 7 days cumulative Eldepryl By Orion Pharma intake is usually followed by an decrease in Guiltiness. (R = -0.099)
Typical values for Guiltiness following a given amount of Eldepryl By Orion Pharma intake over the previous 7 days.
Typical Eldepryl By Orion Pharma intake seen over the previous 7 days preceding the given Guiltiness value.
This chart shows how your Eldepryl By Orion Pharma changes over time.
Each column represents the number of days this value occurred.
This chart shows the typical value recorded for Eldepryl By Orion Pharma on each day of the week.
This chart shows the typical value recorded for Eldepryl By Orion Pharma for each month of the year.
This chart shows how your Guiltiness changes over time.
Each column represents the number of days this value occurred.
This chart shows the typical value recorded for Guiltiness on each day of the week.
This chart shows the typical value recorded for Guiltiness for each month of the year.

Abstract

This individual's Guiltiness is generally 6% lower than normal after 100 milligrams Eldepryl By Orion Pharma per 7 days. This individual's data suggests with a medium degree of confidence (p=0.10480294110689, 95% CI -0.431 to 0.233) that Eldepryl By Orion Pharma has a very weakly negative predictive relationship (R=-0.1) with Guiltiness. The highest quartile of Guiltiness measurements were observed following an average 92.55 milligrams Eldepryl By Orion Pharma per day. The lowest quartile of Guiltiness measurements were observed following an average 95.174418604651 mg Eldepryl By Orion Pharma per day.Guiltiness is generally 6% lower than normal after a total of 95.174418604651 milligrams of Eldepryl By Orion Pharma intake over the previous 7 days. Guiltiness is generally 9% higher after a total of 92.55 milligrams of Eldepryl By Orion Pharma intake over the previous 7 days.

Objective

The objective of this study is to determine the nature of the relationship (if any) between Eldepryl By Orion Pharma and Guiltiness. Additionally, we attempt to determine the Eldepryl By Orion Pharma values most likely to produce optimal Guiltiness values.

Participant Instructions

Record your Eldepryl By Orion Pharma daily in the reminder inbox or using the interactive web or mobile notifications.
Record your Guiltiness daily in the reminder inbox or using the interactive web or mobile notifications.

Design

This study is based on data donated by one participant. Thus, the study design is consistent with an n=1 observational natural experiment.

Data Analysis

Eldepryl By Orion Pharma Pre-Processing
Eldepryl By Orion Pharma measurement values below 0 milligrams were assumed erroneous and removed. No maximum allowed measurement value was defined for Eldepryl By Orion Pharma. It was assumed that any gaps in Eldepryl By Orion Pharma data were unrecorded 0 milligrams measurement values.
Eldepryl By Orion Pharma Analysis Settings

Guiltiness Pre-Processing
Guiltiness measurement values below 1 out of 5 were assumed erroneous and removed. Guiltiness measurement values above 5 out of 5 were assumed erroneous and removed. No missing data filling value was defined for Guiltiness so any gaps in data were just not analyzed instead of assuming zero values for those times.
Guiltiness Analysis Settings

Predictive Analytics
It was assumed that 0.5 hours would pass before a change in Eldepryl By Orion Pharma would produce an observable change in Guiltiness. It was assumed that Eldepryl By Orion Pharma could produce an observable change in Guiltiness for as much as 7 days after the stimulus event.
Predictive Analysis Settings

Data Quantity
459 raw Eldepryl By Orion Pharma measurements with 134 changes spanning 399 days from 2013-07-30 to 2014-09-02 were used in this analysis. 2782 raw Guiltiness measurements with 656 changes spanning 1957 days from 2013-11-17 to 2019-03-29 were used in this analysis.

Data Sources

Eldepryl By Orion Pharma data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Guiltiness data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Limitations

As with any human experiment, it was impossible to control for all potentially confounding variables. Correlation does not necessarily imply causation. We can never know for sure if one factor is definitely the cause of an outcome. However, lack of correlation definitely implies the lack of a causal relationship. Hence, we can with great confidence rule out non-existent relationships. For instance, if we discover no relationship between mood and an antidepressant this information is just as or even more valuable than the discovery that there is a relationship.
We can also take advantage of several characteristics of time series data from many subjects to infer the likelihood of a causal relationship if we do find a correlational relationship. The criteria for causation are a group of minimal conditions necessary to provide adequate evidence of a causal relationship between an incidence and a possible consequence.

The list of the criteria is as follows:
Strength (A.K.A. Effect Size)
A small association does not mean that there is not a causal effect, though the larger the association, the more likely that it is causal. There is a very weakly negative relationship between Eldepryl By Orion Pharma intake and Guiltiness

Consistency (A.K.A. Reproducibility)
Consistent findings observed by different persons in different places with different samples strengthens the likelihood of an effect. Furthermore, in accordance with the law of large numbers (LLN), the predictive power and accuracy of these results will continually grow over time. 139 paired data points were used in this analysis. Assuming that the relationship is merely coincidental, as the participant independently modifies their Eldepryl By Orion Pharma intake values, the observed strength of the relationship will decline until it is below the threshold of significance. To it another way, in the case that we do find a spurious correlation, suggesting that banana intake improves mood for instance, one will likely increase their banana intake. Due to the fact that this correlation is spurious, it is unlikely that you will see a continued and persistent corresponding increase in mood. So over time, the spurious correlation will naturally dissipate.

Specificity
Causation is likely if a very specific population at a specific site and disease with no other likely explanation. The more specific an association between a factor and an effect is, the bigger the probability of a causal relationship.

Temporality
The effect has to occur after the cause (and if there is an expected delay between the cause and expected effect, then the effect must occur after that delay). The confidence in a causal relationship is bolstered by the fact that time-precedence was taken into account in all calculations.

Biological Gradient
Greater exposure should generally lead to greater incidence of the effect. However, in some cases, the mere presence of the factor can trigger the effect. In other cases, an inverse proportion is observed: greater exposure leads to lower incidence.

Plausibility
A plausible bio-chemical mechanism between cause and effect is critical. This is where human brains excel. Based on our responses so far, 1 humans feel that there is a plausible mechanism of action and 0 feel that any relationship observed between Eldepryl By Orion Pharma intake and Guiltiness is coincidental.

Coherence
Coherence between epidemiological and laboratory findings increases the likelihood of an effect. It will be very enlightening to aggregate this data with the data from other participants with similar genetic, diseasomic, environmentomic, and demographic profiles.

Experiment
All of human life can be considered a natural experiment. Occasionally, it is possible to appeal to experimental evidence.

Analogy
The effect of similar factors may be considered.

Relationship Statistics

Property Value
Cause Variable Name Eldepryl By Orion Pharma intake
Effect Variable Name Guiltiness
Sinn Predictive Coefficient 0.1187
Confidence Level medium
Confidence Interval 0.33231988016684
Forward Pearson Correlation Coefficient -0.099
Critical T Value 1.646
Total Eldepryl By Orion Pharma intake Over Previous 7 days Before ABOVE Average Guiltiness 92.55 milligrams
Total Eldepryl By Orion Pharma intake Over Previous 7 days Before BELOW Average Guiltiness 95.174 milligrams
Duration of Action 7 days
Effect Size very weakly negative
Number of Paired Measurements 139
Optimal Pearson Product 0.0053380692495699
P Value 0.10480294110689
Statistical Significance 0.9258
Strength of Relationship 0.33231988016684
Study Type individual
Analysis Performed At 2019-04-04

Eldepryl By Orion Pharma Statistics

Property Value
Variable Name Eldepryl By Orion Pharma
Aggregation Method SUM
Analysis Performed At 2018-12-22
Duration of Action 7 days
Kurtosis 21.411310047427
Mean 1.5436 milligrams
Median 0 milligrams
Minimum Allowed Value 0 milligrams
Number of Changes 134
Number of Correlations 211
Number of Measurements 459
Onset Delay 30 minutes
Standard Deviation 4.8351619897293
Unit Milligrams
Variable ID 86642
Variance 23.378791466923

Guiltiness Statistics

Property Value
Variable Name Guiltiness
Aggregation Method MEAN
Analysis Performed At 2019-03-29
Duration of Action 24 hours
Kurtosis 3.1146355333441
Maximum Allowed Value 5 out of 5
Mean 2.1691 out of 5
Median 2 out of 5
Minimum Allowed Value 1 out of 5
Number of Changes 656
Number of Correlations 5355
Number of Measurements 2782
Onset Delay 0 seconds
Standard Deviation 0.92143458418629
Unit 1 to 5 Rating
Variable ID 1335
Variance 0.84904169293457

Tracking Eldepryl By Orion Pharma

Record your Eldepryl By Orion Pharma daily in the reminder inbox or using the interactive web or mobile notifications.

Tracking Guiltiness

Record your Guiltiness daily in the reminder inbox or using the interactive web or mobile notifications.
Join This Study

https://lh6.googleusercontent.com/-BHr4hyUWqZU/AAAAAAAAAAI/AAAAAAAIG28/2Lv0en738II/photo.jpg Principal Investigator - Mike Sinn